TCL Archive CSR Draft Report Proposes New Panel To Review Clinical Oncology Research February 20, 1998
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007
